BCRT Business Development awarded with EU grant
Together with competence clusters from seven different European countries, and in the context of the ‘Region of Knowledge’ initiative of the 7th Framework Program of the European Union, BCRT’s Business Development has been awarded with a three-year grant.
The goal of this program is to analyze the skill sets of the participating EU partners active in the field of translation in regenerative medicine. Based on the analysis, best-practice guidelines as well as new interregional research and translation programs shall be developed.
BioTOP will act as the regional authority for Berlin-Brandenburg and will support the program with its scientific, clinical and business intelligence that has been build-up competently over the last years.
‘I am optimistic that this program will help to identify new collaborative opportunities within Europe, for the Berlin-Brandenburg Center for Regenerative Therapies (BCRT) as well as for other players in our field and region. The program is in line with our objective to foster international collaborations in regenerative medicine, an effort that has already been awarded with a joint funding program with California in 2009’, says Dr. Frank-Roman Lauter, Head of Business Development at BCRT. BCRT was founded by the Charité, one of the largest university hospitals in Europe and the Helmholtz Association, the largest research association in Germany. Co-funded by those founding partners, as well as the German Ministry for Education and Research (BMBF) and the states of Berlin and Brandenburg, BCRT is developing new solutions to battle diseases of the immune-, the cardiovascular- and the nervous system as well as disorders of the musculoskeletal apparatus.
Dipl. Ing. Aline Pehla
Office of Dr. Frank-Roman Lauter,
Head of Business Development at BCRT
Spokesman of the German-Californian RegMed Initiative
Augustenburger Platz 1
D- 13353 Berlin
<- Back to: News & Events